Literature DB >> 15380355

Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement.

Shlomo Lustig1, Christiana Fogg, J Charles Whitbeck, Bernard Moss.   

Abstract

The two forms of infectious vaccinia virus particles, known as intracellular mature virions and extracellular enveloped virions, are liberated by cell lysis and exocytosis, respectively. The extracellular enveloped form, which is highly resistant to antibody neutralization, contains an outer membrane surrounding an intracellular mature form. We provide evidence that complement mediates antibody-dependent lysis of the outer membrane of extracellular virus, exposing the inner infectious virus to neutralization by a second antibody. These results can help explain the disparity between the in vitro neutralizing and in vivo protective effects of antibodies to extracellular envelope proteins as well as the enhanced protection afforded by specific combinations of antibodies. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380355     DOI: 10.1016/j.virol.2004.07.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice.

Authors:  Kristen N Delaney; James P Phipps; John B Johnson; Steven B Mizel
Journal:  Viral Immunol       Date:  2010-04       Impact factor: 2.257

2.  The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies.

Authors:  Hua-Poo Su; Scott C Garman; Timothy J Allison; Christiana Fogg; Bernard Moss; David N Garboczi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-10       Impact factor: 11.205

Review 3.  Smallpox vaccines: targets of protective immunity.

Authors:  Bernard Moss
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

4.  Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs.

Authors:  Marina Zaitseva; Senta M Kapnick; Clement A Meseda; Elisabeth Shotwell; Lisa R King; Jody Manischewitz; John Scott; Shantha Kodihalli; Michael Merchlinsky; Henriette Nielsen; Johan Lantto; Jerry P Weir; Hana Golding
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  Protective murine and human monoclonal antibodies against eczema vaccinatum.

Authors:  Yoshiaki Tomimori; Yuko Kawakami; Megan M McCausland; Tomoaki Ando; Lilia Koriazova; Shinichiro Kato; Toshiaki Kawakami; Shane Crotty
Journal:  Antivir Ther       Date:  2011

6.  Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.

Authors:  Jitendra Kumar; Viveka Nand Yadav; Swastik Phulera; Ashish Kamble; Avneesh Kumar Gautam; Hemendra Singh Panwar; Arvind Sahu
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

7.  Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.

Authors:  Cassandra L Braxton; Shelby H Puckett; Steven B Mizel; Douglas S Lyles
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

8.  Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.

Authors:  Jay W Hooper; Anthony M Ferro; Joseph W Golden; Peter Silvera; Jeanne Dudek; Kim Alterson; Max Custer; Bryan Rivers; John Morris; Gary Owens; Jonathan F Smith; Kurt I Kamrud
Journal:  Vaccine       Date:  2009-10-13       Impact factor: 3.641

9.  Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.

Authors:  Alonzo D García; Clement A Meseda; Anne E Mayer; Arunima Kumar; Michael Merchlinsky; Jerry P Weir
Journal:  Clin Vaccine Immunol       Date:  2007-06-27

10.  Disparity between levels of in vitro neutralization of vaccinia virus by antibody to the A27 protein and protection of mice against intranasal challenge.

Authors:  Christiana N Fogg; Jeffrey L Americo; Patricia L Earl; Wolfgang Resch; Lydia Aldaz-Carroll; Roselyn J Eisenberg; Gary H Cohen; Bernard Moss
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.